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Revealing serum LMWF for spectral serological diagnostic 
applications 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vibrational spectroscopic techniques can detect small 
variations in molecular content, linked with disease, showing 
promise for screening and early diagnosis. Biological fluids, 
particularly blood serum, are potentially valuable for diagnosis 
purposes. The so-called Low Molecular Weight Fraction 
(LMWF) contains the associated peptidome and metabolome 
and has been identified as potentially the most relevant 
molecular population for disease-associated biomarker 
research. Although vibrational spectroscopy can deliver a 
specific chemical fingerprint of the samples, the High 
Molecular Weight Fraction (HMWF), composed of the most 
abundant serum proteins, strongly dominates the response and 
ultimately makes the detection of minor spectral variations a 
challenging task. Spectroscopic detection of potential serum 
biomarkers present at relatively low concentrations can be 
improved using pre-analytical depletion of the HMWF. In the 
present study, human serum fractionation by centrifugal 
filtration was used prior to analysis by Attenuated Total 
Reflection infrared spectroscopy. Using a model sample based 
on glycine spiked serum, it is demonstrated that the screening 
of the LMWF can be applied to quantify blinded 
concentrations up to 50 times lower. Moreover, the approach 
is easily transferable to different bodily fluids which would 
support the development of more efficient and suitable clinical 
protocols exploring vibrational spectroscopy based ex-vivo 
diagnostic tools. 
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1.  Introduction 
Vibrational spectroscopic techniques have been 
extensively evaluated for their capacity to deliver a 
specific molecular fingerprint closely linked to the disease 
state [1-5]. Ranging from tissue to single cell analysis, 
both infrared and Raman spectroscopy are promising 
techniques with potential clinical applications [6]. 
Spectral imaging of biopsies using FTIR or Raman 
confocal micro-spectroscopy has proven the potential of 
these approaches for the identification of pathological 
areas delivering additional histological information for 
diagnosis based on the molecular profiles of the samples. 
Applied to single cell analysis, the specificity of the 
techniques allows in vitro screening of toxicological 
effects of ionising radiation, nanoparticles or the action of 
chemotherapeutic agents at the subcellular level [7-12]. 
Recently, vibrational spectroscopy in the field of spectral 
cytology performed on cervical samples for the detection 
of abnormal cells based on their chemical composition has 
attracted more attention [13, 14]. However, diseases such 
as cancer could remain asymptomatic until they reach a 
stage of development too advanced for effective treatment, 
and therefore routine screening for early detection is 
crucial to improve patient prognosis. In this context, 
bodily fluids are of great interest [15], and, although urine 
or saliva could be attractive candidates for patients 
screening and monitoring [16, 17], blood serum remains 
potentially the most valuable alternative to identify 
reliable biomarkers for diagnosis purposes [18].   
The development of proteomic technologies with medical 
perspectives needs to align with clinical requirements 
such as compatibility with large patient cohort analysis, 
speed and cost effectiveness to enable clinical translation 
of these promising technologies. Analysis of human 
serum for the identification of disease-associated 
biomarkers is a challenging task, with numerous obstacles 
to overcome. For instance, in recent studies investigating 
the feasibility to develop methods for proteomic 
investigation, the high protein content (i.e. 60±80 mg/ml) 
could be interpreted as a beneficial attribute of the sample 
[19]. Indeed, with about 25% of all proteins encoded by 
the genome predicted to be secreted, serum is a rich source 
of biochemical products that can act as biomarkers of 
disease or physiological status of a patient [20]. It is 
expected that, by measuring concentrations of specific 
molecular species in the serum, the presence of disease 
associated proteins being secreted and shed from cells and 
tissues can be determined. For example, increased serum 
levels of prostate-specific antigen (PSA) and CA125 are 
routinely used for the in vitro detection of cancer in the 
prostate and ovary in clinic routines [21]. However, the 
main limiting characteristic of the serum is the dynamic 
range of concentrations observed between the abundant, 
high molecular weight and the sparse, low molecular 
weight proteins. As a part of the high molecular weight 
fraction (HMWF), proteins such as human serum albumin 
(HSA) (57±71%) and globulins (8±26%), completely 
dominate the composition of the serum quantitatively but 
only account for 0.1% of the total number of protein 
species. Consequently, many potentially important 
molecules and markers can escape detection, due to 
difficulties in monitoring the smaller, less abundant serum 
constituents. For example, proteolysis within the tissue or 
deregulated post-translational events participate in 
fragmentation of proteins produced in the tumors that 
diffuse into the circulation [22]. Disease biomarkers are 
often low-molecular-weight proteins/peptides, exhibiting 
far greater tumor and vascular permeability due to their 
molecular size range, and are thus secreted into the 
bloodstream as a result of the disease process. The Low 
PROHFXODUZHLJKWIUDFWLRQ/0:)N'DSODVPDRU
serum proteome has been the focus of recent attempts to 
identify novel diagnostic and prognostic cancer 
biomarkers [23, 24]. The LMWF holds much promise for 
identification of diagnostics or prognostic markers, 
further supported by recent associations of pathological 
conditions with small protein and peptide profiles in 
serum, notably for diabetes [25], cardiovascular or 
infectious diseases [26]. The analytical capabilities of 
traditional proteomic methods are limited given the large 
dynamic range of concentrations in the serum. Therefore, 
depletion of the highly abundant proteins is now 
recognized as the first step, yet to be optimized, in the 
analysis of the serum proteome. A key challenge in 
identifying constituents in the LMWF in the serum is to 
overcome the 10 orders of magnitude concentration 
difference between the least abundant (interleukins, 
cytokines < 5 pg/mL) and the most abundant (albumin: up 
to 60 mg/mL).  
Infrared and Raman spectroscopy have great potential for 
serum based detection of disease biomarkers in serum [27, 
28]. However, the techniques suffer from similar 
limitations to those encountered with chromatography 
and/or mass spectroscopy based approaches. Highly 
abundant proteins can strongly dominate the data 
collected, making it difficult to detect small variations in 
the features related to the presence of the informative low 
molecular weight proteins/peptides [29]. This present 
study details a proof of concept approach, combining 
centrifugal filtration with Attenuated Total Reflection 
infrared (ATR-IR) spectroscopy for the detection of 
glycine (selected as a small model 
biomolecule/biomarker) within the complex human serum 
mixture. The filtration approach is an attractive alternative 
to time consuming separation techniques such as 
chromatography, offering a rapid and specific 
fractionation of proteins according to molecular weight 
without the need for chemical extraction that could affect 
the spectral profiles recorded. The spectroscopic approach 
is demonstrated as a highly sensitive, label free method of 
detecting and quantifying the small molecule within the 
LMWF. 
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2.  Experimental  
2.1 Sample preparation 
 
Sterile filtered human serum from normal mixed pool (off 
the clot) was donated by the University Hospital CHU 
Angers (France) as part of the Cancéropôle du Grand-
Ouest consortium. Commercially available centrifugal 
filtering devices, Amicon Ultra-0.5ml (Millipore - Merck, 
Germany), with cut-off points at 10 kDa, were employed 
in this study, as an illustrative example. As a result, 2 
fractions were obtained following filtration; the first 
representing proteins with a molecular weight higher than 
the cut off point of the filter used (concentrate); the second 
corresponding to the fraction passed by the membrane and 
collected in the vial (filtrate). The serum was 1:10 diluted 
in distilled H2O prior to processing, 0.5 mL of the solution 
being placed in the centrifugal filter for spinning, in order 
to minimize any potential effects of mechanical strain and 
clogging on the filter membrane. The procedure for 
washing the centrifugal devices prior to serum analysis 
was adapted from [30] EDVHG RQ PDQXIDFWXUHU¶V
guidelines, and performed as follows: The Amicon Ultra-
0.5ml filter was spun thrice with a solution of NaOH 
(0.1M), followed by 3 rinses with Milli-Q water 
(Millipore Elix S). For both washing and rinsing, 0.5 mL 
of the respective liquid was added to the filters and the 
centrifugation was applied for 10 mins at 14 000g 
followed by a spinning with the devices upside down at 
1000g for 2 mins in order to remove any residual solution 
contained in the filter.  
 
Additionally, Albumin from human serum (Sigma-
Aldrich, Ireland) and glycine (Cooper, France) were 
analysed as reference chemical compounds for the 
evaluation of the centrifugal filtration process. Notably, 
glycine has been selected because it is the smallest amino 
acid, having a molecular weight of 75 Da, which results in 
free diffusion through the membrane of the centrifugal 
filters and can serve as a model for LMWF peptides. 
Firstly, the whole human serum sample has been 
supplemented with known concentrations of glycine; 0.0 
mg/mL (control), 0.5 mg/mL, 1 mg/mL, 2.5 mg/mL, 5 
mg/mL, 7.5 mg/mL, 10 mg/mL, 17.5 mg/mL, 25 mg/mL 
and 50mg/mL, in order to explore the dynamic range and 
sensitivities of the ATR-IR measurement of unprocessed 
samples. Therefore, the concentrations has been selected 
to cover a wide range of concentrations from extremely 
high, non-clinically relevant, to relatively low in order to 
better understand and explore the capabilities and 
behavior of the ATR-IR instruments in humans serum 
monitoring. Secondly, a stock solution corresponding to 
the LMWF, prepared following centrifugal filtration with 
the 10kDa filters, has been supplemented with  known 
concentrations of glycine of 0.01 mg/mL, 0.05 mg/mL, 
0.1 mg/mL, 0.25 mg/mL, 0.5 mg/mL, 1 mg/mL, 2 mg/mL 
and 2.5 mg/mL. The serum stock solution without 
addition of glycine has been used as a reference to build 
the regression models. 
 
2.2 Dry mass measurements 
 
In order to calculate total dry mass of the samples, it is 
necessary to freeze-dry (lyophilize) the samples. Thus, 
freeze drying was performed using a Labonco lyophilizer 
(Freezone, USA), whereby the vials have been placed 
overnight at -51°C and under vacuum (<0.05 mBar). This 
procedure has been applied on sets of whole human serum 
(n =3) and following ultrafiltration with a 10kDa filter 
(n=3) to estimate to overall dry mass but also determine 
the amount of biological material recovered in the filtrated 
fractions, corresponding to the LMWF.      
 
2.3 Data collection using the ATR-IR  
ATR-IR spectra were recorded using a Bruker vector 22 
equipped with a UATR module. Sample penetration is 
both wavenumber and sample dependent, but is typically 
on the order of 1µm. Spectral data were the result of 16 
scans, with a spectral resolution of 4 cm-1 covering the 
spectral window 4000 ± 600 cm-1. A background spectrum 
was also recorded (64 scans) and automatically rationed 
with the sample spectrum by the software.  
 
Whole human serum: The spectroscopic analysis of 
samples was performed directly after deposition of a drop 
on the crystal (0.5 µL, to ensure sample coverage is less 
than the full area of the crystal, minimizing the effects of 
inhomogeneities), while still in liquid form and also in a 
dry state following 10 min air drying prior to recording. 
10 replicates have been performed for each serum sample. 
 
Filtered fraction of the human serum: The relatively weak 
concentrations of the filtrates (LMWF) following 
centrifugal filtrations using a 10kDa filter have been 
found to greatly impact on the spectral data collected. The 
freeze drying process was therefore used to re-concentrate 
the molecules present in the LMWF. Based on a protocol 
detailed above, 400 µL of the filtrate were processed and 
the resulting lyophilized material was re-suspended in 
distilled water (20 µL). However, the recording of IR 
spectra from the LMWF in the liquid form has still been 
found not relevant due to the signal to noise ratio exhibited 
and only air drying of the drops deposited on the crystal 
has allowed to generate relevant data. Similarly to whole 
human, 0.5 µL has been deposited on the crystal and 10 
replicates have been performed for each sample. 
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2.4 Size exclusion chromatography (SEC) 
SEC was performed on an Alliance e2695 (Waters) 
equipped with both Wyatt miniDawn Treos and Optilab 
T-rEx (Wyatt Technology Europe GmbH) detectors. 50 
µL of each serum sample was injected onto A SHODEX 
KW803 column (300 mm x 7.8 mm) and separated at a 
flow rate of 0.7 mL/minute using PBS (pH 7.2) as elution 
buffer. The PDA 2998 apparatus (Waters) was employed 
for the UV detection at 280 nm, while the MALLS 
detection was performed with a three-angle (43.6°; 90.0°; 
136.4°) miniDawn Treos detector (Wyatt Technology 
Europe) operating with a 60-mW solid-state laser at 658 
nm. For consistency, a total elution time of 25 mins was 
used for all samples. The whole serum being highly 
concentrated, a 1:50 dilution was prepared prior to SEC 
analysis. In comparison, the LMW filtrates were analyzed 
without any further dilution, since they were obtained 
after centrifugal filtration performed on diluted serum 
(1:10).  
 
2.5 Data pre-processing and analysis 
The different pre-processing and data analysis steps were 
performed using Matlab (Mathworks, USA) with the 
unsupervised attribute of Principal Component Analysis 
(PCA) exploited as an approach to highlight and quantify 
the spectral variability generated by the addition of known 
concentrations of glycine to the human serum.  
The analysis of the spectra collected has been restricted to 
the finger print region where the water contribution is less 
pronounced. While the spectra collected from liquid 
samples have been min-max normalised on the water band 
at 1636 cm-1, the spectra collected from the air dried whole 
serum and the filtered samples (LMWF) were processed 
using baseline correction (rubber-band) followed by 
vector normalization. This enabled the observation and 
evaluation of the systemic variations in the data following 
the increased of glycine with the PCA analysis. Vector 
normalization has been found to be particularly suitable 
for this study in order to equalize the contribution of the 
different serum physiological constituents in the spectra 
collected between sets and further enhance the systematic 
variations in the glycine features. Ultimately the PCA 
analysis performed on the whole finger print region 
reflects the evolution of band ratios in the data, such that 
the features of the mixed pool serum act as internal 
standards such that the added glycine can be quantified. It 
should be noted that, for each tested condition the lowest 
concentration of glycine prepared (0.5 mg/mL or 0.01 
mg/mL) has been excluded from the regression model and 
kept as a blinded sample to verify and validate the 
robustness of the method.     
3.  Results and discussion 
 
3.1 ATR-IR detection of a single model 
biomolecule  
Analysis of molecules using infrared spectroscopy can be 
performed following a number of different set ups, 
depending on the instrumentation available. Most 
traditionally, the spectra are recorded using the 
transmission mode, involving the IR beam passing 
through the sample. However, the ATR (Attenuated Total 
Reflectance) mode is particularly adapted for the analysis 
of highly concentrated liquid samples [31]. Notably, the 
approach does not require expensive spectroscopic 
substrates and the planar, easily washable surface offered 
by the crystal is an advantage for repeated measurements. 
Therefore, a drop can be directly deposited onto the 
crystal, delivering high quality spectra without saturation 
that can be encountered with transmission mode 
measurements [32]. Liquid samples can be analysed and 
characterised using ATR-IR spectra, but the sensitivity of 
the information collected directly depends on the 
concentration of the solution. Figure 1 presents IR spectra 
collected from aqueous solutions of glycine (200 mg/mL) 
XVLQJ WKH$75PRGHRIVROXWLRQµZHW¶ VDPSOH )LJXUH
1A) and following air drying (Figure 1B). The limited 
spectral region of 1800-650cm-1 was chosen to avoid the 
regions of strong water absorption in the liquid samples, 
and to minimise any effects of incomplete drying in dried 
samples, thus enabling better comparison between liquid 
and dried samples. While the spectrum obtained from the 
solution exhibits the specific features of glycine, the 
contribution of the spectrum of deionised water can still 
be observed (dotted line). However, specific features of 
glycine such as CH2 rocking (914 cm-1), C-N stretching 
(1039 cm-1), N-H3 rocking (1117 cm-1), C-H2 wagging 
(1333 cm-1) or O-C=O symmetric stretching (1412 cm-1) 
are easily identifiable. The band at 1333 cm-1 is 
particularly interesting due to its strong relative intensity 
but also its positioning remote from the main water band 
(1636 cm-1), and is thus used for further analysis in Figure 
2. The spectrum collected from the solution of glycine 
following air drying (Figure 1B) exhibits notable 
modifications that could result from aggregation and/or 
crystallization effects (e.g. bands between ~1100 ± 1150 
cm-1). The main spectral features are, however, preserved.    
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Figure 1: Typical ATR IR spectrum collected from solution 
µZHW¶VDPSOHVRIJO\FLQHDWPJP/GHSRVLWHGRQWKH$75
crystal (A) and after air-drying (B). No preprocessing has been 
applied. Additionally the dotted line represents the contribution 
of the water to the signal collected from the solution. The spectra 
have been offset for clarity and the main features of interest are 
highlighted in grey.  
 
Figure 2 presents the concentration dependence of the area 
under the curve observed in raw data (AUC ± between 
baseline and peak maximum) calculated for the band 
1360-1280 cm-1 from solution of glycine (figure 2 ± blue) 
and following air drying (figure 2 - red). Note, the spectra 
have not been normalized. In the case of the liquid 
samples, the thickness of the droplet exceeds the 
penetration depth of the ATR evanescent wave, and the 
systematic increase of the solution concentration results in 
a linear correlation between the concentration of glycine 
and the intensity of the signal (R2 = 0.9999), in accordance 
with the Beer-Lambert law. In the dry sample, all the 
dissolved glycine is deposited on the crystal surface and 
therefore is sampled by the evanescent wave, resulting in 
a substantially larger absorbance for all concentrations 
and a steeper initial increase in the concentration 
dependence. However, the linearity of the measurement 
response is lost when the thickness of the dried sample 
exceeds the depth of penetration of the evanescent wave. 
Therefore, as seen in figure 2 (red dots), above 25 mg/mL 
there is a saturation of the IR absorbance. Indeed, this 
effect can only be clearly seen in unprocessed data 
collected from dry samples, as the commonly employed 
normalization steps of the preprocessing protocol would 
compensate for the loss of intensity in the spectra. 
However, the observations highlight the fact that, 
following air drying, the Beer-Lambert type dependence 
of the absorbance on concentration and length of the 
optical path are both partially lost and the critical 
parameter is the amount of matter deposited. Thus, while 
a linear dependence of the absorbance is observed over a 
wider range for the liquid samples, for the dried samples, 
increased sensitivity is achievable at the lower end of the 
concentration range. 
 
 
Figure 2: Evolution of Area Under the Curve (AUC) of the band 
1360-1280 cm-1 as a function of glycine concentrations. The blue 
squares represent the measurement performed from the sample 
in liquid form while the red dots correspond to the samples 
deposited after air-drying. The dotted line represents a linear fit 
to the liquid form data. 
 
 
3.2 Analysis of human blood serum  
Although recording reproducible IR spectra from human 
serum could appear an easy task due to the particularly 
high concentration of protein content, specificity towards 
detection of minority species could be severely limited 
because of the complexity of the signal collected. 
Although human serum is naturally highly concentrated, 
spectra collected for the liquid form are still dominated by 
the water contribution (Figure 3A). In contrast, the water 
free spectrum collected after air drying (Figure 3B) 
displays numerous well defined peaks within the 4000-
650 cm-1 spectral widow, allowing clearly identification 
of specific features of the human serum, for example those 
highlighted in grey at 3280 cm-1  (H±O±H stretching), 
2957 cm-1 (Asymmetric CH3 stretching), 2920 cm-1  
(Asymmetric CH2 stretching), 2872 cm-1  (Symmetric CH3 
stretching), 1536 cm-1 (Amide II of proteins), 1453 cm-1 
(CH2 scissoring), 1394 cm-1 (C=O stretch of COO±), 1242 
cm-1  (Asymmetric PO2 stretch), 1171 cm-1 (Ester C±O 
asymmetric stretch) and  1080 cm-1 (C±O stretch) [33-35]. 
However, the dried serum spectrum is very similar to the 
spectrum collected from similarly dried human serum 
albumin (HSA), as a result of its high concentration in 
human serum (Figure 3D). This example perfectly 
illustrates the spectral dominance that can be observed 
from the contributions of the abundant proteins of the 
HMWF (Figure 3C). The spectra of these proteins swamp 
the contribution of less represented biomolecules, raising 
the question to whether or not minor variations of minority 
components can be detected and quantified.    
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Figure 3: Typical ATR IR spectrum of a 5 mg/mL air dried 
human serum albumin solution (A) compared to the HMWF 
concentrated with a 10kDa filter (B); the human unfiltered serum 
following air drying (C) and in its liquid form (D). Spectra have 
been offset for clarity with the main features highlighted in grey. 
No spectral preprocessing has been applied. 
 
3.3 Detection of Molecules in human serum  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: A: Mean ATR-IR spectra collected from unprocessed 
whole human serum (a) and supplemented with 0.5 mg/mL, 1 
mg/mL, 2.5 mg/mL, 5 mg/mL, 7.5 mg/mL, 10 mg/mL, 17.5 
mg/mL, 25 mg/mL and 50 mg/mL of glycine (respectively b-j)- 
Spectra offset for clarity; B: Scatter plot from the PCA 
performed on ATR-IR spectra collected from the different 
solutions. Colour coding has been used to better identify the 
different groups of spectra. The top arrow indicates the 
distribution of the data across the scatter plot according to 
concentrations of glycine added; C: Loadings 1 and 2 
corresponding to the PCA analysis performed on serum 
solutions (respectively blue and red); D: Linear regression fit of 
ATR-IR absorption versus concentration of glycine in whole 
human serum in solution. The plot represents the distance 
between each groups and the un-supplemented serum (0 mg/mL) 
calculated using the PC_1 score from the PCA. 
 
In order to build a model to mimic variations that could 
naturally occur in the LMWF, pure lyophilized glycine 
has been added at known and variable concentrations to 
human serum. Following the collection of ATR-IR 
spectra, the capabilities of the technique have been 
evaluated through the monitoring of systematic spectral 
modifications in the data sets, despite the presence of 
dominant HMW proteins. Thus, a wide range of 
concentrations has been used for the analyses which have 
been performed in both liquid and dried forms, in order to 
evaluate the sensitivity and determine the specificity 
offered by the experimental set up used. Concentrations 
covering the range 0.5 mg/ml to 50 mg/mL have been 
found most suited to illustrate the capabilities of the ATR-
IR toward whole human serum analysis. Although the 
concentrations used for illustration are not necessarily 
physiologically relevant, the limits of the tested range 
have been purposely extended in order to offer better 
appreciation of the spectral behavior for various amounts 
of glycine.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The mean IR spectra collected from the different samples 
prepared (liquid) are presented in figure 4A, organized 
from bottom to top according to the concentrations of 
glycine added to the whole human serum, and off-set for 
clarity. A stock solution of human mixed pool serum has 
been used in this study in order to have a consistent basis 
for the preparation of the samples and ensuring that the 
chemical composition only varies based on the added 
quantities of glycine. 
The data collected from the samples have been analyzed 
by Principal Component Analysis (PCA), delivering, in an 
unsupervised fashion, the variance between the data sets, 
either graphically with the scatter plot or through the 
loadings expressing the discriminating spectral features 
[36]. The results corresponding to the PCA performed on 
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spectra collected from the liquid samples supplemented 
with glycine compared to the un-supplemented serum 
stock solution are presented in figure 4B. The distribution 
along the PC 1 axis is directly related to the variation of 
concentration of glycine added to the human serum, an 
observation confirmed by the loading of PC1, accounting 
for 98.12% of the variance and displayed in figure 4C.  
While a clear discrimination between the different clusters 
can be seen at the highest concentrations (figure 4B top 
arrow), the degree of separation is strongly reduced when 
the concentrations of glycine added are below 10 mg/mL, 
especially for the 2.5 mg/mL (yellow dots), 1 mg/mL 
(blue dots) and 0.5 mg/mL (green dots).      
PC 2 only accounts for 0.58% of variance which indicates 
quite minor variations in the spectra collected. The 
spectral profile of PC2 (Figure 4B) does not clearly 
correlate with the glycine spectrum. The positions of the 
different clusters formed by the spectra along the PC 2 
axis are, however, not correlated with the concentration of 
glycine and the inter and intra cluster variability could 
thus be attributed to instrumental or experimental 
variability.  
While the loading of PC 1 exhibits a spectral profile 
identical to the pure solution of glycine (figure 1A), the 
loading of PC 2 (figure 4Cb) is particularly noisy and does 
not exhibit any clear features which can be 
unambiguously related to spectral features of glycine. 
This is further supported by the 0.58% of variance 
expressed by PC 2, clearly highlighting the absence of 
relevant discriminative information along this PC. It 
should be noted that, in order to remove the tail effect 
visible in figure 4A due to the presence of water in the 
liquid samples, the PCA analysis has been performed on 
the range 1800-1000 cm-1.  
PCA remains a powerful tool, widely employed for data 
mining and in particular for studies aiming to discriminate 
data groups for diagnostic purposes [36]. The chemical 
information obtained from the loadings allows correlation 
of the distribution of the data points across the scatter plot 
with specific variations in the spectra, and, in this 
instance, to confirm the contribution of the glycine 
signature to the observed variance. Moreover, the location 
of each spectrum in the scatterplot is defined by scores 
along both PC 1 and PC 2 (figure 4B) which can be 
assimilated to coordinates positioning the groups with 
respect to each other. Therefore, the most different 
spectra, according to a specific PC, will be separated by a 
greater distance than those exhibiting stronger 
similarities. Ultimately, when the limit of specificity of 
the information contained in the spectra has been reached, 
no more discrimination would be discernible on the scatter 
plot, meaning that, score wise, the spectra would be 
characterized by similar values along the relevant PC.  
 
To represent this, firstly, the mean score values for each 
tested concentration of glycine are evaluated for PC 1 
using Mi   scores/ni (with ni = number of spectra for a 
given concentration). Secondly, the distance between each 
group and the un-supplemented serum (0 mg/mL) has 
EHHQFDOFXODWHG¨PC = Mi ± M0 mg/mL). Finally, the degree 
of separation has been expressed using Eq.1: 
 
[L ¨3&Bi2)1/2                          (1) 
(i: different concentrations tested ) 
 
Considering the case of liquid human serum, PC 2, 
accounting for only 0.58% of the variance, can be 
disregarded, as there is no clear correlation with the 
systematic change in concentration. Finally, the values 
calculated can be plotted against the different 
concentrations of glycine added in the whole serum, as 
presented in figure 4D. The results for the analysis of 
liquid samples display acceptable linearity (R2 = 0.9993). 
Note that the regression model has been built without 
taking onto account the lowest concentration, 0.5 mg/mL, 
which has been then used as a blinded sample to evaluate 
the sensitivity of the methods. Accordingly, the 10 
replicates from the 0.5 mg/mL sample have been inputted 
into the regression model giving an average predicted 
value of 0.45 mg/mL +/- 0.16 mg/mL.  
In order to better evaluate the impact of working from 
liquid serum samples, the drops deposited on the ATR 
crystal have been air dried before recording in order to 
collect water free spectra. The resulting mean spectra are 
displayed in figure 5A, and the corresponding results from 
the PCA are presented in figure 5B, 5C and 5D. The 
absence of water bands greatly improves the visibility of 
the different features resulting from both the human serum 
constituents and the added glycine. The distribution of the 
different groups of spectra on the scatter plot follows a 
different pattern, both PC 1 and PC 2 being influenced by 
the presence of the glycine. As a consequence, the 
loadings 1 and 2 exhibit similar spectral features of this 
model amino acid and they respectively account for 98.2% 
and 1.4% of the explained variance. However, the spectra 
collected from the samples supplemented with 50 mg/mL 
glycine have been considered as outliers and excluded 
from the data set to build the regression model. It appears 
that such high concentration generated a quite different 
spectral profile, potentially due to aggregation, leading to 
difficulties in interpreting the peak position and intensity 
compared to lower concentrations (figure 5A). 
 
Therefore, although the PC 2 expresses 1.4% of the 
explained variance only the PC 1 was used for the 
calculation of the degree of separation between the 
different clusters formed on the scatter plot, as described 
in equation (1).      
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The curve obtained from the PC 1 score according to 
Equation 1 exhibits quite a different profile compared to 
the liquid samples, as seen in figure 5D, with a deviation 
from linearity apparent above ~ 10mg/mL, similar to the 
case for dried glycine in Figure 1. The relationship 
between the glycine concentration in the serum and the 
variations observed in the spectra can be expressed by 
means of a polynomial fitting, giving a R2 value of 0.9978. 
Polynomial expansions are common in the mathematical 
description of many physical phenomena, including 
perturbation theory of, for example an anharmonic 
oscillator, or non-linear optics. In the case of 
concentration dependent effects, higher order terms are 
commonly employed to account for intermolecular 
interactions, e.g. aggregation [37]. Similar to the liquid 
samples, the spectra collected from the 0.5 mg/mL 
samples have been inputted into the regression model, 
delivering a predicted value of 0.383 +/- 0.007 mg/mL.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: A: Mean ATR IR spectra collected from unprocessed 
whole human serum (a) and supplemented with 0.5 mg/mL, 1 
mg/mL, 2.5 mg/mL, 5 mg/mL, 7.5 mg/mL, 10 mg/mL, 17.5 
mg/mL, 25 mg/mL and 50 mg/mL of glycine (respectively b-j) - 
offset for clarity; B: Scatter plot from the PCA performed on 
ATR-IR spectra collected from the different solutions. Colour 
coding has been used to better identify the different groups of 
spectra. The top arrow indicates the distribution of the data 
across the scatter plot according to concentrations of glycine 
added; C: Loadings 1 and 2 corresponding to the PCA analysis 
performed on serum-based solutions (respectively blue and red); 
D: Polynomial regression fit of ATR-IR absorption versus 
concentration of glycine in whole human serum in solution. The 
plot represents the distance between each groups and the un-
supplemented serum (0 mg/mL) calculated using the PC_1 score 
from the PCA. 
 
The ATR-IR measurement setup used in this study is 
perfectly suited for the analysis of complex mixtures. The 
direct deposition of solutions onto the crystal would offer 
the two options to collect the data from the liquid samples 
or following air drying. Ultimately, high quality spectra 
capturing the overall chemical composition can be 
collected, as highlighted with the unprocessed data 
displayed in figure 1 and figure 3. Both approaches deliver 
predicted values in the range of the blinded samples 
tested, although they underestimate the real concentration.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Although removing a dominant molecule such as H2O 
from the signal collected could be expected to enhance the 
relative contribution of other weaker bands, resulting in a 
better separation of the different data groups, only the 
standard deviation has been improved but the accuracy 
remains unacceptable. Although those results are 
encouraging, in the context of human serum analysis, the 
difficulty comes from unbalanced concentrations existing 
between the different constituents. For example, Albumin 
itself represents about 50% of the overall composition 
which, combined with other abundant proteins such as 
immunoglobulin, fibrinogen or transferrin, brings this 
number up to 90%. As a result, the LMWF of the serum 
represents only 1% of the total composition [21]. 
Therefore, similar to other approaches to identifying 
serum biomarkers, such as chromatography and mass 
spectroscopy [22], the potential of vibrational 
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spectroscopy techniques could also be greatly improved 
when coupled with optimised sample preparation methods 
aiming to isolate the LMWF for more specific spectral 
characterisation.   
 
3.4 Centrifugal filtration and HMW protein 
depletion  
Mass spectroscopy is the most commonly reported 
technique for the recent investigations screening the 
LMWF for disease-related information, probing and 
profiling proteomic information of hundreds of candidate 
disease biomarkers without the need for a priori 
knowledge of their existence or relevance to disease states 
[38-40]. Facing the complexity of human serum, most 
approaches aiming for the identification and validation of 
LMWF diagnostic biomarkers have introduced HMWF 
depletion in their protocols [41]. Although ATR-IR 
spectroscopy is an attractive, rapid and cost effective 
alternative for the screening of patient samples in order to 
deliver a specific diagnostic, similarly to mass 
spectroscopy, the depletion of abundant proteins 
(HMWF) is a non-optional step in the investigation of the 
relevant fraction of the serum, in order to highlight and 
potentially target small circulating biomolecules. When 
applying vibrational spectroscopy techniques for rapid 
screening of human body fluids, numerous constraints 
towards the integrity of the samples need to be considered 
in order to provide an adapted and optimised 
methodology. While a wide range of chemical 
extraction/precipitation protocols of the HMWF can be 
found in the literature [42, 43], the impact of the solvents 
involved in the different steps is unclear, considering that 
most of them would exhibit strong IR features, 
contributing to the spectra collected, adding complexity to 
the identification of specific spectral variations in serum 
biomolecules. Commercially available centrifugal 
filtration devices such as the Amicon ultra-0.5 (Merk 
0LOOLSRUHSURYLGHDVVWDWHGE\WKHPDQXIDFWXUHU³DIDVW
ultrafiltration, with the capability for high concentration 
factors and easy concentrate recovery from the dilute and 
FRPSOH[PDWULFHV´7KLVDVSHFWKDVDOUHDG\EHHQH[SORUHG
in previous studies which demonstrated that the 
concentrating factor of 10, when centrifuging human 
serum at 14000g for 30 mins, offers possibilities for 
analysing samples in liquid form with both IR and Raman 
spectroscopy [33]. The main advantage of this approach 
resides in the centrifugal separation of the molecules 
based on their sizes without the need for additional 
solvents, resulting in the preservation of the biomolecules 
from the serum as close as possible to their native forms. 
Another attractive aspect of the centrifugal centrifugation 
for biomedical applications is the possibility to collect 
both the concentrated HMW and the filtered LMW 
fractions. For instance, using a 10kDa cut-off point, the 
depletion of abundant proteins with high molecular 
weight can be achieved, as only small biomolecules are 
able to freely pass through the membrane, providing a 
perfectly suited in vitro tool for quick separation of 
molecular species for subsequent spectroscopic 
characterisation [44].  
Evaluation of the efficiency of the HMW protein 
depletion has been performed based on size exclusion 
chromatography (Figure 6). The whole unprocessed 
human serum, presented in Figure 6A, has been used as 
reference in order to visualise the different features 
present and defined windows on the chromatogram 
corresponding to relevant elution times. The regions 
corresponding to the HMWF and LMWF have been 
highlighted and are respectively found between elution 
times of 9-15 mins and 19-22 mins. The dominant peak, 
positioned at 14 mins, corresponds to the contribution of 
albumin, the most abundant protein in human serum 
(Figure 6B). Comparison of the data collected from 
unprocessed (Figure 6A) and 10kDa filtered human serum 
samples (Figure 6C) clearly highlights a strong decrease 
in the intensities of the bands located in the HMWF 
window of the chromatogram. In order to enable a better 
estimation of the degree of depletion achieved, the Area 
Under the Curve (AUC) for the albumin peak was 
calculated. Considering the dilution factors used for the 
sample preparation, an average of 0.16% remaining 
albumin can be found in the samples following centrifugal 
filtration (Table 1). Although, only done in triplicates, the 
reproducibility of the HMW proteins depletion has been 
found quite acceptable with remaining percentages of 
albumin comprised between 0% and 0.37%. According to 
the chromatogram, most of the HMWF proteins are 
characterised by higher molecular masses, with elution 
times between 9-14 mins (Figure 6A). Therefore, an 
efficient depletion of the albumin would also impact on 
the other abundant proteins. Finally, the LMWF has been 
found to be totally preserved during the centrifugal 
filtration process. A similar AUC analysis for the peak 
located around 20 mins, estimated values of 0.188 +/- 
0.004 and 0.190+/-0.012 for the whole unprocessed and 
the 10kDa filtered human serum respectively (Figure 6A 
and 6C).  
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Figure 6: Size Exclusion Chromatography performed on A: 
Whole serum (1:50 dilution); B: Human serum albumin (1 
mg/mL); and C: Filtrate obtained from human serum after 
centrifugal filtration using a 10kDa device (serum diluted 1:10 
prior to centrifugation) and Chromatograms off set for clarity. 
The regions corresponding to the High Molecular Weight 
Fraction (HMWF) and the Low Molecular Weight Fraction 
(LMWF) have been highlighted. 
 
Table 1: Area Under the Curve (AUC) calculated for the 
albumin peak observed in the chromatograms displayed in figure 
6. The percentage of Albumin (Alb) takes into account the 
dilution factors used for the sample preparation. 
 Whole serum 
Filtrate 
(10kDa) 
AUC (min-max) 0.4725 - 0.5048 0 ± 0.0115 
AUC (average / 
STD) 
0.489 +/- 0.023 0.004 +/- 0.0053 
Vol injected (µl) 50 50 
Dilution factor 50 10 
% HSA (average) 100% (reference) 0.16% 
 
 
 
 
 
 
 
 
3.5 Centrifugal filtration for human serum 
LMWF spectroscopic analysis   
Following centrifugal filtration using 10kDa filters, the 
depletion of abundant proteins can be efficiently achieved 
as highlighted using exclusion chromatography. The 
removal of the HMWF will naturally have huge 
consequences on the IR spectra collected from the filtered 
part of the serum. The glycine, selected as a model, being 
the smallest amino acid, will freely pass through the 
centrifugal device membrane and be collected with the 
LMWF. Samples of whole serum and filtrates obtained 
from centrifugal filtration with 10kDa filters have been 
prepared by freeze drying and weighing of lyophilisates 
was performed to quantify the amounts. In the present 
case, the serum stock solution used in this study has an 
initial concentration of 98.5 +/- 0.2 mg/mL, taking into 
account all molecular species naturally present in the 
serum, while, after processing with centrifugal filtration, 
the LMWF was found to be 13.3 +/- 0.5 mg/mL. 
Therefore, the range of concentrations of glycine analysed 
for filtered human serum has been considerably reduced, 
extending from 0.01 mg/mL to 2.5 mg/mL. 
The mean spectra collected from the different LMWF dry 
samples are presented in figure 7. Based on a similar 
approach to the one used previously on whole serum, the 
position for each group of data has been estimated 
according to the scores corresponding to PC 1 (see 
equation 1) and a correlation curve has been drawn. Once 
again, the curve follows a polynomial pattern and a trend 
line can be fitted with R2 = 0.9981. Following depletion of 
the abundant proteins, the sensitivity for the detection of 
glycine has been considerably improved and the 
regression model built allows to deliver a predicted value 
of 0.011 mg/mL +/- 0.006 mg/mL, for the 0.01mg/mL 
sample. Although the standard deviation remains quite 
high compared to the average predicted value, the 
depletion of HMW proteins greatly enhanced the 
sensitivity of the method. The main limitations 
encountered remain purely technical, as both the LMWF 
fraction and the added glycine are particularly low in 
concentrations which make the data collected strongly 
influenced by the reproducibility of the drops deposited. 
A much lower standard deviation could easily be achieved 
using an automated system for deposition rather than 
micropipettes which could lead to uncertainties.     
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Figure 7: A: Mean ATR IR spectra collected from the 
ultrafiltetered human serum (a) and supplemented with 0.01 
mg/mL, 0.05 mg/mL, 0.1 mg/mL, 0.25 mg/mL, 0.5 mg/mL, 1 
mg/mL, 2 mg/mL and 2.5 mg/mL of glycine (respectively b-i)- 
offset for clarity; B: Scatter plot from the PCA performed on 
ATR-IR spectra collected from the different solutions. Colour 
coding has been used to better identify the different groups of 
spectra. The top arrow indicates the distribution of the data 
across the scatter plot according to concentrations of glycine 
added; C: Loadings 1 and 2 corresponding to the PCA analysis 
performed on serum solutions (respectively blue and red); D: 
Polynomial regression fit of ATR-IR absorption versus 
concentration of glycine in whole human serum in solution. The 
plot represents the distance between each groups and un-
supplemented serum (0 mg/mL) calculated using the PC1 score 
from the PCA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
 
 
 
 
 
3.6 Discussion 
The focus in the field of clinical serology has recently 
been shifted to an unexplored reservoir of potentially 
relevant biomolecules gathered in the LMWF of the 
proteome, incorporating their metabolic products 
(peptidome). While the LMWF serum peptidome has been 
dismissed as too small to be biologically relevant, it has 
been also been reported that this fraction may contain a 
rich, untapped source of disease-specific diagnostic 
information [44, 45]. The low molecular mass range (<10 
kDa) remains largely uncharacterized but promises to 
contain a precious source of previously undiscovered 
biomarkers, mostly because it has now been recognized to 
contain shed proteins and protein fragments (clipped or 
cleaved) originating from physiologic and pathologic 
events taking place in all perfused tissues [43, 45, 46]. 
While the size of HMW proteins prevents them from 
entering the circulation, fragments from those could be 
found in the serum proteome, mixed with the normal 
constituents, the remaining challenge being to detect them 
among the broad molecular population.  
The metabolites are physiological constituents of the 
human serum LMWF that can potentially reflect a 
SDWLHQW¶VKHDOWKVWDWXV9DULDWLRQVLQWKHLUFRQFHQWUDWLRQV
can be a good indicator to detect undergoing pathological 
processes, and therefore as physiological markers for 
rapid diagnostics. Glucose remains the most common 
example, but also one of most targeted molecules for the 
development of ex vivo quantitative models, notably IR 
spectroscopy [47, 48]. While the normal average 
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concentration for glucose is roughly about 0.8 mg/mL 
[49], making its detection achievable in whole serum, 
monitoring and estimation of its blood levels based on 
spectral features will be significantly limited in the 
presence of highly abundant proteins (HMWF). With a 
molecular mass of 180 Da, glucose can freely pass 
through the 10kDa centrifugal devices used is this work 
and be collected entirely in the filtered fraction. That 
means blood glucose levels could be determined more 
accurately but also that the spectroscopic analysis could 
be used for patients with extremely low glucose levels 
located in the range of a few µg/mL, which is not 
achievable before HMWF depletion. Moreover, glucose 
remains one of the most abundant metabolites found in the 
human serum, which probably explains its recurrent 
apparition in the literature. The methodology proposed 
here opens numerous perspectives toward the broadening 
of applications as a direct consequence of the isolation of 
the LMWF to potentially reveal the contribution of 
numerous other metabolites which will fall within the 
lowered limit of detection range estimated [50]. For 
instance, most amino acids can be found naturally in the 
human serum, levels ranging from 0.262 mg/mL (proline), 
to 0.0132 mg/mL (alanine) to 0.024 mg/mL (glycine), 
0.023 mg/mL (phenylalanine). Moreover, a large number 
of other metabolites with clinical potential for health 
monitoring can be found in human serum [49, 50], 
including, as examples, lactate (acid base homeostasis), 
creatinine (renal health) or carnitine (heart dysfunction), 
with respective normal concentrations documented at 0.29 
mg/mL, 0.009 mg/mL and 0.005 mg/mL [50]. 
Centrifugation can processes many vials at the same time, 
and thus is much faster than for example chromatographic 
separation techniques. The study demonstrates the 
potential advantages of spectroscopic methods over the 
subsequent analysis techniques. Simplifying the serum 
composition by depletion could lead to the development 
of more suitable methods for in vitro diagnostics which, 
coupled to the considerable improvements made in recent 
years in the field of data preprocessing and analysis, will 
allow accurate and reproducible models for quantitative 
screening of key molecules present in the LMWF to be 
built.   
4.  Conclusion 
The rapid increase of scientific works referenced in the 
literature demonstrates the growing interest in translating 
and adapting the capabilities of vibrational spectroscopic 
techniques to the development of serological diagnostic 
methods. However, little or no consideration has been 
given to the protocols employed for sample preparation, 
leading to a poor relevancy of the outcomes due to the 
high degree of complexity of the serum. Although 
vibrational spectroscopy delivers the chemical fingerprint 
of the analyzed samples, with, in principle, contributions 
from all molecular species present, the limit of detection 
found experimentally would suggest that performing 
analysis on whole human serum will imply negligible 
contribution from numerous constituents present at low 
concentrations. Human serum screening, and by extension 
all body fluids, is still an emerging field of application and 
in order to strengthen the position of Infrared and Raman 
spectroscopy as clinical tools, numerous questions need to 
be considered and addressed by the community, firstly, to 
be in accordance with other approaches currently used 
such as Mass spectroscopy and secondly, be able to 
deliver clinically relevant information for diagnosis. 
Adapting and optimizing sample preparation methods 
have a considerable impact on the sensitivity of the 
spectroscopic analysis of the LMWF of the human serum. 
The model built on glycine monitored by ATR-IR clearly 
demonstrates that removal of water, by drying, and the 
HMWF, by centrifugal filtration, leads to an improvement 
of the sensitivity of the technique which allowed to 
identify blinded concentrations of glycine up to 50 times 
lower compared to whole human serum.   Furthermore, as 
the sample processing is also applicable to a wider range 
of body fluids, the methodology presented in the present 
work will certainly be beneficial for the field and lead to 
drastic improvements in the strategies oriented toward 
their implementation as the next generation of diagnostics 
techniques clinical tools.   
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Text:  
 
The Low Molecular Weight Fraction (LMWF) of serum holds 
great potential for diagnostics and health monitoring. The low 
concentrations of peptides and metabolites compared to highly 
abundant proteins remain a challenging obstacle to overcome. In 
order to collect specific chemical fingerprint from small serum 
biomolecules using vibrational spectroscopy techniques, High 
Molecular Weight (HMW) proteins depletion is required. 
Physical separation by mean of ultrafiltration offers a new 
dimension in serological diagnostic and further support the 
potential of Infrared and Raman spectroscopy as clinical tools.      
 
 
 
 
 
